Cited by 951Schizophrenia research and treatmentCardiac Health and Mental HealthDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 150 of the 152 references it cites were found in a registry or an index.

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

De Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I.G., Möller, H.-J.·2009·European Psychiatry

DOI 10.1016/j.eurpsy.2009.01.005

Open this paper in CoChat — free account

Abstract

People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder, have worse physical health and reduced life expectancy compared to the general population. The excess cardiovascular mortality associated with schizophrenia and bipolar disorder is attributed in part to an increased risk of the modifiable coronary heart disease risk factors; obesity, smoking, diabetes, hypertension and dyslipidaemia. Antipsychotic medication and possibly other psychotropic medication like antidepressants can induce weight gain or worsen other metabolic cardiovascular risk factors. Patients may have limited access to general healthcare with less opportunity for cardiovascular risk screening and prevention than would be expected in a non-psychiatric population. The European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) published this statement with the aim of improving the care of patients suffering from severe mental illness. The intention is to initiate cooperation and shared care between the different healthcare professionals and to increase the awareness of psychiatrists and primary care physicians caring for patients with severe mental illness to screen and treat cardiovascular risk factors and diabetes.

Integrity signals

Registry

Crossref · 10.1016/j.eurpsy.2009.01.005

Cites

150 of 150 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Obesity and physical activity: A review
Bensimhon, D., Kraus, W. E., & Donahue, M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.005 · Cited by 122
Retracted
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“- Document téléchargé le 23/06/2011 par AS OF EUROPEAN diabetes [78,131].”
Background
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
Self-citation
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Diagnosis and Classification of diabetes mellitus
Rossi, G. (2014) · Diapedia.org eBooks · doi:10.14496/dia..20 · Cited by 3,212
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.
Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999) · Circulation · doi:10.1161/01.cir.99.16.2192 · Cited by 2,846

Show all 152 references

Research works printed but not linked: 8

10.1176/ajp.2006.163.4.611 · DOI
Scheen, 2008, Traitement neuroleptique et troubles metabolic, Med Mal Metabol, 2, 593
Correll, 2008, Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents, J Clin Psychiatry, 69, 26
Citrome, 2007, Risk-Benefit Analysis of Available Treatments for Schizophrenia, Psychiatric Times, 1, 27
2008, Clinical Practice Guidelines for the prevention and management of diabetes in Canada, Can J Diabetes, 32, S1
Casey, 2004, Antipsychotic-Induced Weight Gain and Metabolic Abnormalities: Implications for Increased Mortality in Patients With Schizophrenia, J Clin Psychiatry, 65, 4
Henderson, 2005, Schizophrenia and comorbid metabolic disorders, J Clin Psychiatry, 66, 11
Nicol, 2009, Preliminary results of the MEAC study: metabolic effects of antipsychotics in children, Schizophr Bull, 35, 32

Sorted by citations

Items 101–200 of 948

Clozapine for the treatment of schizophrenia
Fakra, É., & Azorin, J. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.709235 · Cited by 82
Prevalence of the metabolic syndrome in unipolar major depression
Kahl, K. G., Greggersen, W., Schweiger, U., Cordes, J., Balijepalli, C., Lösch, C., & Moebus, S. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0277-4 · Cited by 79
Self-citation
The functional exercise capacity is correlated with global functioning in patients with schizophrenia
Vancampfort, D., Probst, M., Scheewe, T. W., Knapen, J., Herdt, A. D., & Hert, M. A. F. D. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01825.x · Cited by 81
A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications
Beary, M., Hodgson, R., & Wildgust, H. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112440512 · Cited by 79
Implementing evidence-based physical activity interventions for people with mental illness: an Australian perspective
Rosenbaum, S., Tiedemann, A., Stanton, R., Parker, A. G., Waterreus, A. J., Curtis, J., & Ward, P. B. (2015) · Australasian Psychiatry · doi:10.1177/1039856215590252 · Cited by 88
Perceptions of mental health nurses and patients about health promotion in mental health care: a literature review
Verhaeghe, N., Maeseneer, J. D., Maes, L., Heeringen, C. V., & Annemans, L. (2011) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2011.01692.x · Cited by 77
Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder
Tkachev, A., Stekolshchikova, E., Vanyushkina, A., Zhang, H., Morozova, A. Y., Zozulya, S. A., Kurochkin, I., Anikanov, N. A., Egorova, A., Yushina, E., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.4350 · Cited by 77
Reducing excess mortality due to chronic disease in people with severe mental illness: Meta-review of health interventions
Baxter, A. J., Harris, M., Khatib, Y., Brugha, T. S., Bien, H., & Bhui, K. S. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.115.163170 · Cited by 82
Breaking the habit: a qualitative exploration of barriers and facilitators to smoking cessation in people with enduring mental health problems
Kerr, S., Woods, C., Knussen, C., Watson, H. E., & Hunter, R. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-221 · Cited by 76
Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study
Masopust, J., Malý, R., Andrýs, C., Vališ, M., Bažant, J., & Hosák, L. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-2 · Cited by 75
Cardiovascular effects of psychotic illnesses and antipsychotic therapy
Howell, S., Yarovova, E., Khwanda, A., & Rosen, S. D. (2019) · Heart · doi:10.1136/heartjnl-2017-312107 · Cited by 74
Barriers to Somatic Health Care for Persons With Severe Mental Illness in Belgium: A Qualitative Study of Patients' and Healthcare Professionals' Perspectives
Kohn, L., Christiaens, W., Detraux, J., Lepeleire, J. D., Binder, M. D., Gillain, B., Delaunoit, B., Savoye, I., Mistiaen, P., & Jespers, V. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.798530 · Cited by 93
Does Switching Antipsychotics Ameliorate Weight Gain in Patients With Severe Mental Illness? A Systematic Review and Meta-analysis
Siskind, D. J., Gallagher, E., Winckel, K., Hollingworth, S., Kisely, S. R., Firth, J., Correll, C. U., & Marteene, W. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa191 · Cited by 76
Using Smartphone Apps to Promote Psychiatric and Physical Well-Being
Macias, C., Panch, T., Hicks, Y. M., Scolnick, J. S., Weene, D. L., Öngür, D., & Cohen, B. M. (2015) · Psychiatric Quarterly · doi:10.1007/s11126-015-9337-7 · Cited by 76
Allostatic Load as a Tool for Monitoring Physiological Dysregulations and Comorbidities in Patients with Severe Mental Illnesses
Bízik, G., Picard, M. A., Nijjar, R., Tourjman, V., McEwen, B. S., LUPIEN, S. J., & Juster, R. (2013) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000012 · Cited by 76
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
Keks, N. A., Hope, J., Schwartz, D., McLennan, H., Copolov, D., & Meadows, G. N. (2020) · CNS Drugs · doi:10.1007/s40263-020-00718-4 · Cited by 74
Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment
Reynolds, G. P., & McGowan, O. O. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117722987 · Cited by 67
Comorbidity of Physical Disorders Among Patients With Severe Mental Illness With and Without Substance Use Disorders: A Systematic Review and Meta-Analysis
Onyeka, I. N., Høegh, M. C., Eien, E. M. N., Nwaru, B. I., & Melle, I. S. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1619007 · Cited by 69
Rethinking psychopharmacotherapy: the role of treatment context and brain plasticity in antidepressant and antipsychotic interventions.
Rief, W., Barsky, A. J., Bingel, U., Doering, B. K., Schwarting, R., Wöhr, M., & Schweiger, U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.11.008 · Cited by 67
Does metabolic syndrome or its component factors alter the course of bipolar disorder? A systematic review
Giménez‐Palomo, A., Gomes‐da‐Costa, S., Dodd, S., Pacchiarotti, I., Verdolini, N., Vieta, E., & Berk, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.026 · Cited by 70
Mental health practitioners’ reported barriers to prescription of exercise for mental health consumers
Way, K. A., Kannis‐Dymand, L., Lastella, M., & Lovell, G. P. (2018) · Mental health and physical activity · doi:10.1016/j.mhpa.2018.01.001 · Cited by 69
Adhesive capsulitis: An age related symptom of metabolic syndrome and chronic low-grade inflammation?
Pietrzak, M. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.01.002 · Cited by 67
Prevalence of the metabolic syndrome in patients with borderline personality disorder: results from a cross-sectional study
Kahl, K. G., Greggersen, W., Schweiger, U., Cordes, J., Correll, C. U., Frieling, H., Balijepalli, C., Lösch, C., & Moebus, S. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0339-2 · Cited by 68
Self-citation
The Effectiveness of Lifestyle Interventions to Reduce Cardiovascular Risk in Patients with Severe Mental Disorders: Meta-Analysis of Intervention Studies
Martin, M., Martín‐Lopez, L. M., Masa-Font, R., Tabueña, N. O., Roman, Y. M., Martín‐Royo, J., Canet, S. O., Tejón, S. G., San-Emeterio, L., García, A. B., et al. (2013) · Community Mental Health Journal · doi:10.1007/s10597-013-9614-6 · Cited by 66
Antipsychotic drug use and risk of stroke and myocardial infarction: a systematic review and meta-analysis
Zivkovic, S., Koh, C. H., Kaza, N., & Jackson, C. A. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2177-5 · Cited by 65
Physical health in schizophrenia: a challenge for antipsychotic therapy
Heald, A. (2010) · European psychiatry · doi:10.1016/s0924-9338(10)71700-4 · Cited by 71
Association of the metabolic syndrome with physical activity performance in patients with schizophrenia
Vancampfort, D., Sweers, K., Probst, M., Maurissen, K., Knapen, J., Minguet, P., & Hert, M. A. F. D. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.12.007 · Cited by 65
EPA guidance on the quality of mental health services
Gäebel, W., Becker, T. M., Janssen, B., Munk‐Jørgensen, P., Musalek, M., Wulf Rössler, A., Sommerlad, K., Tansella, M., Thornicroft, G., & Zielasek, J. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.12.001 · Cited by 66
H1-histamine receptor affinity predicts weight gain with antidepressants
Salvi, V., Mencacci, C., & Barone‐Adesi, F. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.08.012 · Cited by 65
Healthy eating in persons with serious mental illnesses: Understanding and barriers.
Barré, L. K., Ferron, J. C., Davis, K. E., & Whitley, R. (2011) · Psychiatric Rehabilitation Journal · doi:10.2975/34.4.2011.304.310 · Cited by 64
Age at onset of psychotic disorder: Cannabis, BDNF Val66Met, and sex‐specific models of gene–environment interaction
Decoster, J., van Os, J., Kenis, G., Henquet, C., Peuskens, J., Binder, M. D., & van Winkel, R. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31174 · Cited by 64
An ethnographic study of the incentives and barriers to lifestyle interventions for people with severe mental illness
Roberts, S. H., & Bailey, J. E. (2013) · Journal of Advanced Nursing · doi:10.1111/jan.12136 · Cited by 64
Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia
Marteene, W., Winckel, K., Hollingworth, S., Kisely, S. R., Gallagher, E., Hahn, M., Ebdrup, B. H., Firth, J., & Siskind, D. J. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1674809 · Cited by 62
A narrative review of the success of intramuscular gluteal injections and its impact in psychiatry
Soliman, E., Ranjan, S., Xu, T., Gee, C., Harker, A., Barrera, A., & Geddes, J. (2018) · Bio-Design and Manufacturing · doi:10.1007/s42242-018-0018-x · Cited by 61
Factors Associated with Influenza Vaccination Decisions among Patients with Mental Illness
Lorenz, R. A., Norris, M. M., Norton, L. C., & Westrick, S. C. (2013) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.46.1.a · Cited by 61
Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives
Chang, S.-C., Goh, K. K., & Lu, M. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i10.696 · Cited by 72
Cardiometabolic effects of physical activity interventions for people with schizophrenia
Vancampfort, D., Knapen, J., Binder, M. D., van Winkel, R., Deckx, S., Maurissen, K., Peuskens, J., Simons, J., & Probst, M. (2009) · Physical Therapy Reviews · doi:10.1179/108331909x12540993898053 · Cited by 61
Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations
Stogios, N., Humber, B. E., Agarwal, S. M., & Hahn, M. (2023) · Current Psychiatry Reports · doi:10.1007/s11920-023-01458-0 · Cited by 60
MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study
van Winkel, R., Moons, T., Peerbooms, O., Rutten, B. P. F., Peuskens, J., Claes, S. J., van Os, J., & Binder, M. D. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833bc60d · Cited by 59
Interventions for the metabolic syndrome in schizophrenia: a review
Papanastasiou, E. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812458697 · Cited by 64
Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data
Wu, L.-T. T., Ghitza, U. E., Batch, B. C., Pencina, M. J., Rojas, L. F., Goldstein, B. A., Schibler, T., Dunham, A. A., Rusincovitch, S. A., & Brady, K. T. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.09.003 · Cited by 61
Analysis of gut microbiota and their metabolic potential in patients with schizophrenia treated with olanzapine: results from a six-week observational prospective cohort study
Pełka-Wysiecka, J., Kaczmarczyk, M., Bąba-Kubiś, A., Liśkiewicz, P., Wroński, M., Skonieczna-Żydecka, K., Marlicz, W., Misiak, B., Starzyńska, T., Kucharska-Mazur, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101605 · Cited by 59
“Therefore, dietary counseling and weight management, including regular bodyweight measurements, should be implemented as soon as the OLZ therapy begins [24,25].”
Background
Efficacy of lifestyle interventions in physical health management of patients with severe mental illness
Chacón, F., Mora, F., Gervás-Ríos, A., & Gilaberte, I. (2011) · Annals of General Psychiatry · doi:10.1186/1744-859x-10-22 · Cited by 61
Health promotion in mental health care: perceptions from patients and mental health nurses
Verhaeghe, N., Maeseneer, J. D., Maes, L., Heeringen, C. V., & Annemans, L. (2013) · Journal of Clinical Nursing · doi:10.1111/jocn.12076 · Cited by 58
Physical health management in psychiatric settings
Hert, M. A. F. D., van Winkel, R., Silić, A., Eyck, D. V., & Peuskens, J. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71702-8 · Cited by 58
Increased Cardiovascular Disease Risk in Veterans With Mental Illness
Vance, M. C., Wiitala, W. L., Sussman, J. B., Pfeiffer, P., & Hayward, R. A. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.005563 · Cited by 57
What is needed to deliver collaborative care to address comorbidity more effectively for adults with a severe mental illness?
Lee, S. J., Crowther, E., Keating, C., & Kulkarni, J. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412463975 · Cited by 57
Cardiometabolic risk factors, physical activity and psychiatric status in patients in long-term psychiatric inpatient departments
Ringen, P. A., Færden, A., Antonsen, B. T., Falk, R. S., Mamen, A., Rognli, E. B., Solberg, D. K., Andreassen, O. A., & Martinsen, E. W. (2018) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2018.1449012 · Cited by 56
Extensive bidirectional genetic overlap between bipolar disorder and cardiovascular disease phenotypes
Rødevand, L. N., Bahrami, S., Frei, O., Chu, Y., Shadrin, A. A., O’Connell, K. S., Smeland, O. B., Elvsåshagen, T., Hindley, G., Djurovic, S., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01527-z · Cited by 55
Can high intensity interval training improve health outcomes among people with mental illness? A systematic review and preliminary meta-analysis of intervention studies across a range of mental illnesses
Martland, R., Mondelli, V., Gaughran, F., & Stubbs, B. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.039 · Cited by 54
Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study
Vieta, E., Owen, R., Baudelet, C., McQuade, R. D., Sanchez, R., & Marcus, R. N. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003779380 · Cited by 51
From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism
Castillo-Passi, R. I., Rojo, L. E., Henríquez‐Henríquez, M., Hernán Silva, I., Maturana, A., Villar, M. J., Fuentes, M., & Gaspar, P. A. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00488 · Cited by 59
The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia
Li, Q., Du, X., Zhang, Y., Yin, G., Zhang, G., Walss‐Bass, C., Quevedo, J., Soares, J. C., Xia, H., Li, X., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.12.041 · Cited by 52
The lived experience of severe mental illness and long-term conditions: a qualitative exploration of service user, carer, and healthcare professional perspectives on self-managing co-existing mental and physical conditions
Carswell, C., Brown, J. V. E., Lister, J., Ajjan, R., Alderson, S. L., Balogun-Katung, A., Bellass, S., Double, K., Gilbody, S. M., Hewitt, C. E., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04117-5 · Cited by 55
Self-citation
The effect of exercise on global, social, daily living and occupational functioning in people living with schizophrenia: A systematic review and meta-analysis
Korman, N., Stanton, R., Vecchio, A., Chapman, J. J., Parker, S., Martland, R., Siskind, D. J., & Firth, J. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.04.012 · Cited by 51
National evaluation of obesity screening and treatment among veterans with and without mental health disorders.
Littman, A. J., Damschroder, L., Verchinina, L., Lai, Z.-S., Kim, H. M., Hoerster, K. D., Klingaman, E. A., Goldberg, R. W., Owen, R., & Goodrich, D. E. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.11.005 · Cited by 50
Type 2 diabetes mellitus in people with severe mental illness: inequalities by ethnicity and age. Cross‐sectional analysis of 588 408 records from the UK
Das‐Munshi, J., Ashworth, M. J., Dewey, M. E., Gaughran, F., Hull, S., Morgan, C., Nazroo, J. Y., Petersen, I., Schofield, P., Stewart, R. J., et al. (2016) · Diabetic Medicine · doi:10.1111/dme.13298 · Cited by 52
Epidemiology and comorbidity of severe mental illnesses in the community: findings from a computerized mental health registry in a large Israeli health organization
Kodesh, A., Goldshtein, I., Gelkopf, M., Goren, I., Chodick, G., & Shalev, V. (2012) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-012-0478-9 · Cited by 53
Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia
Mauriño, J., Sicras‐Mainar, A., Ruíz-Beato, E., & Navarro‐Artieda, R. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75449 · Cited by 55
Mental health services funding and development in KwaZulu-Natal: A tale of inequity and neglect
Burns, J. K. (2010) · South African Medical Journal · doi:10.7196/samj.4100 · Cited by 50
Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis
Bak, M., Drukker, M., Cortenraad, S. A. M., Vandenberk, E., & Gülöksüz, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244944 · Cited by 55
The effect of bariatric surgery on psychiatric course among patients with bipolar disorder
Ahmed, A. T., Warton, E. M., Schaefer, C. A., Shen, L., & McIntyre, R. S. (2013) · Bipolar Disorders · doi:10.1111/bdi.12109 · Cited by 48
High mortality and low access to care following incident acute myocardial infarction in individuals with schizophrenia
Kurdyak, P. A., Vigod, S. N., Calzavara, A. J., & Wodchis, W. P. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.09.003 · Cited by 49
History, background, concepts and current use of comedication and polypharmacy in psychiatry
Möller, H. ‐., Seemüller, F., Schennach-Wolff, R., Stübner, S., Rüther, E., & Grohmann, R. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000837 · Cited by 52
Self-citation
Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics
Ventriglio, A., Baldessarini, R. J., Vitrani, G., Bonfitto, I., Cecere, A. C., Rinaldi, A., Petito, A., & Bellomo, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00744 · Cited by 49
Increased Risk of Diabetes Mellitus Among Persons With Psychotic Symptoms: Results From the WHO World Health Survey
Nuevo, R., Chatterji, S., Fraguas, D., Verdes, E., Naidoo, N., Arango, C., & Ayuso-Mateos, J. L. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06801 · Cited by 48
Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics
Moschny, N., Hefner, G., Grohmann, R., Eckermann, G., Maier, H. B., Seifert, J., Heck, J., Francis, F., Bleich, S., Toto, S., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14060514 · Cited by 53
SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects
Haddad, P. M., Fleischhacker, W. W., Peuskens, J., Cavallaro, R., Lean, M. E. J., Ma, M., Reynolds, G. P., Azorin, J., Thomas, P., & Möller, H. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125313510195 · Cited by 48
Self-citation
Variation in Psychotropic Medication Prescription for Adults With Schizophrenia in the United States
Bareis, N., Olfson, M., Wall, M. M., & Stroup, T. S. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000932 · Cited by 49
The Diagnosis and Treatment of Bipolar Disorder
Culpepper, L. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01609 · Cited by 49
The Health Benefits and Challenges of Exercise Training in Persons Living with Schizophrenia: A Pilot Study
Bredin, S. S. D., Warburton, D. E. R., & Lang, D. J. (2013) · Brain Sciences · doi:10.3390/brainsci3020821 · Cited by 54
Metabolic syndrome in psychiatry: advances in understanding and management
Ho, C. S. H., Zhang, M. W., Mak, A., & Ho, R. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.113.011619 · Cited by 47
Sex Differences in Body Mass Index and Obesity in Chinese Patients With Chronic Schizophrenia
Li, Q., Chen, D., Liu, T., Walss‐Bass, C., Quevedo, J., Soares, J. C., Zhao, J., & Zhang, X. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000594 · Cited by 47
Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade
Rødevand, L. N., Steen, N. E., Elvsåshagen, T., Quintana, D. S., Reponen, E. J., Mørch, R. H., Lunding, S. H., Vedal, T. S. J., Dieset, I., Melle, I. S., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13008 · Cited by 47
Screening for cardiovascular risk in patients with severe mental illness in primary care: A comparison with patients with diabetes
Hardy, S., Hinks, P., & Gray, R. J. (2013) · Journal of Mental Health · doi:10.3109/09638237.2012.759194 · Cited by 46
Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population
Choong, E., Bondolfi, G., Etter, M., Jermann, F., Aubry, J., Bartolomei, J., Gholam‐Rezaee, M., & Eap, C. B. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.01.014 · Cited by 46
Swedish clinical guidelines—Prevention and management of metabolic risk in patients with severe psychiatric disorders
Gothefors, D., Adolfsson, R., Attvall, S., Erlinge, D., Jarbin, H., Lindström, K., von Hausswolff‐Juhlin, Y., Morgell, R., Toft, E., & Ösby, U. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2010.500397 · Cited by 46
Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysis
Boreu, Q. F., Martin, M., Flores‐Mateo, G., Zabaleta‐del‐Olmo, E., Ayerbe, L., López, M. P.-P., Martín‐Lopez, L. M., Montes‐Hidalgo, J., & Violán, C. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0833-6 · Cited by 46
Mechanisms in endocrinology: Antipsychotic medication and type 2 diabetes and impaired glucose regulation
Whicher, C. A., Price, H. C., & Holt, R. I. G. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0022 · Cited by 47
Self-citation
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications
Squassina, A., Manchia, M., Pisanu, C., Ardau, R., Arzedi, C., Bocchetta, A., Caria, P., Cocco, C., Congiu, D., Cossu, E., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00844-z · Cited by 50
Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: Results from a 3-month prospective open-label study
Wampers, M., Hanssens, L., van Winkel, R., Heald, A. H., Collette, J., Peuskens, J., Reginster, J., Scheen, A. J., & Binder, M. D. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.010 · Cited by 46
Understanding the role of physiotherapists in schizophrenia: an international perspective from members of the International Organisation of Physical Therapists in Mental Health (IOPTMH)
Stubbs, B., Soundy, A., Probst, M., Hert, M. D., Herdt, A. D., & Vancampfort, D. (2014) · Journal of Mental Health · doi:10.3109/09638237.2013.869574 · Cited by 46
Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics
Krane‐Gartiser, K., Breum, L., Glümer, C., Linneberg, A. R., Madsen, M., Køster, A., Jepsen, P. W., & Fink‐Jensen, A. (2011) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.565799 · Cited by 45
Physical health monitoring in mental health settings: a study exploring mental health nurses’ views of their role
Mwebe, H. P. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13653 · Cited by 43
Metabolic Effects of Antidepressant Treatment
Olguner Eker, O., Ozsoy, S., Eker, B., & Dogan, H. (2017) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2016.12373 · Cited by 44
Perspectives on implementing HIIT interventions for service users in inpatient mental health settings: A qualitative study investigating patient, carer and staff attitudes
Martland, R., Gaughran, F., Stubbs, B., & Onwumere, J. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.01.065 · Cited by 44
Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein
Dieset, I., Hope, S., Ueland, T., Bjella, T. D., Agartz, I., Melle, I. S., Aukrust, P., Røssberg, J. I., & Andreassen, O. A. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.040 · Cited by 43
Obesity in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates and relationship with cognitive deficits
Tian, Y., Liu, D., Wang, D., Wang, J., Xu, H., Dai, Q., Andriescue, E. C., Wu, H. E., Xiu, M., Chen, D., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.10.017 · Cited by 43
Diabetes and cardiovascular risk in severe mental illness: a missed opportunity and challenge for the future
Holt, R., & Peveler, R. (2010) · Practical Diabetes · doi:10.1002/pdi.1451 · Cited by 44
Self-citation
Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors
Saloojee, S., Burns, J. K., & Motala, A. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149209 · Cited by 42
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I. M., Backer, G. D., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0157 · Cited by 48
Self-citation
How to treat mania
Pacchiarotti, I., Anmella, G., Colomer, L., & Vieta, E. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13209 · Cited by 48
Impact of Co-Morbid Mental Illness on the Diagnosis and Management of Patients Hospitalized for Medical Conditions in a General Hospital
Briskman, I., Bar, G., Boaz, M., & Shargorodsky, M. (2012) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.43.4.d · Cited by 54
Health Behaviors, Knowledge, Life Satisfaction, and Wellbeing in People with Mental Illness across Four Countries and Comparisons with Normative Sample
Parletta, N., Aljeesh, Y. I., & Baune, B. T. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00145 · Cited by 40
The chasm of care: Where does the mental health nursing responsibility lie for the physical health care of people with severe mental illness?
Wynaden, D., Heslop, B., Heslop, K., Barr, L., Lim, E., Chee, G.-L., Porter, J., & Murdock, J. (2016) · International Journal of Mental Health Nursing · doi:10.1111/inm.12242 · Cited by 41
Why are somatic diseases in bipolar disorder insufficiently treated?
Nielsen, R. E., Kugathasan, P., Straszek, S. P. V., Jensen, S. E., & Licht, R. W. (2019) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0147-y · Cited by 44
“That’s all Fake”: Health professionals stigma and physical healthcare of people living with Serious Mental Illness
Rivera-Segarra, E., Varas‐Díaz, N., & Santos‐Figueroa, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226401 · Cited by 53
Management of physical health in patients with schizophrenia: practical recommendations
Heald, A. H., Montejo, A. L., Millar, H. L., Hert, M. A. F. D., McCrae, J., & Correll, C. U. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71706-5 · Cited by 41
Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder
Kasteng, F., Eriksson, J. W., Sennfält, K., & Lindgren, P. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01716.x · Cited by 41
Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial
Verhaeghe, N., Clays, E., Vereecken, C. A., Maeseneer, J. D., Maes, L., Heeringen, C. V., Bacquer, D. D., & Annemans, L. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-657 · Cited by 39

Authors: De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J.
Affiliations: KU Leuven (BE)
Imperial College London (GB)
Medizinische Hochschule Hannover (DE)
University of Southampton (GB)
Ludwig-Maximilians-Universität München (DE)
ORCID: Wood, D.
Holt, R.I.G.
Venue: European Psychiatry
Publisher: Cambridge University Press (CUP)
Published: 2009-09
Volume: 24
Issue: 6
Pages: 412-424
ISSN: 0924-9338 (ISSN-L)
1778-3585
DOI: 10.1016/j.eurpsy.2009.01.005
OpenAlex: W2154493342
Cited by: 951
References: 152
Citations by year: 2026: 27 · 2025: 32 · 2024: 37 · 2023: 61 · 2022: 42 · 2021: 64 · 2020: 59 · 2019: 62 · 2018: 46 · 2017: 44 · 2016: 69 · 2015: 63 · 2014: 71 · 2013: 66 · 2012: 65
FWCI: 42.54
Type: journal article
Language: en
Open access: closed
Licence: www.cambridge.org/core/terms (unspecified, 3880 d)
Locations: European Psychiatry (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
Lirias (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: Bristol-Myers Squibb
European Society of Cardiology
European Association for the Study of Diabetes
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: severe mental illness, cardiovascular disease, diabetes mellitus, schizophrenia, bipolar disorder, depression, cardiovascular risk factors, antipsychotic-induced weight gain, psychotropic drugs, cardiovascular risk screening, cardiovascular disease prevention, shared care, life expectancy, coronary artery disease
MeSH terms: Bipolar Disorder, Cardiovascular Diseases, Cause of Death, Cross-Sectional Studies, Major Depressive Disorder, Diabetes Mellitus, Follow-Up Studies, Humans, Mass Screening, Obesity, Psychotic Disorders, Psychotropic Drugs, Risk Factors, Schizophrenia, Societies, Medical, Comorbidity, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks